A quantitative meta-analysis of olfactory dysfunction in mild cognitive impairment

David R Roalf1, Madelyn J Moberg1, Bruce I Turetsky1

  • 1Department of Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

Abstract

Insights

Olfactory deficits are common in mild cognitive impairment (MCI), particularly in odour identification. This suggests smell tests could help screen for Alzheimer's disease (AD) risk.

Area of Science:

  • Neuroscience
  • Gerontology
  • Psychology

Background:

  • Alzheimer's disease (AD) is linked to olfactory deficits.
  • Olfactory dysfunction may indicate cognitive decline and dementia.
  • Mild cognitive impairment (MCI) is a transitional stage between normal aging and dementia.

Purpose of the Study:

  • To conduct a meta-analysis on olfactory deficits in MCI.
  • To characterize the nature and extent of olfactory impairments in MCI patients.

Main Methods:

  • Comprehensive literature search of PubMed, MEDLINE, and PsychInfo databases up to June 2016.
  • Meta-analysis of 31 articles including 1993 MCI patients and 2861 healthy older adults (HOA).
  • Weighted effect size computation to control for sample size differences.

Main Results:

  • Significant, moderate-to-large olfactory deficits found in MCI compared to HOA (d=-0.76).
  • Odour identification tests showed larger effect sizes than detection or memory tests.
  • Male MCI patients exhibited greater olfactory deficits; older females performed better.

Conclusions:

  • Olfactory deficits are a robust finding in MCI.
  • Impaired odour identification in MCI mirrors deficits seen in AD.
  • Odour identification tests are recommended for screening individuals at risk for AD.